ATE258946T1 - Verfahren zur herstellung von polyamidketten von genauer länge und deren konjugate mit proteinen - Google Patents
Verfahren zur herstellung von polyamidketten von genauer länge und deren konjugate mit proteinenInfo
- Publication number
- ATE258946T1 ATE258946T1 AT99943873T AT99943873T ATE258946T1 AT E258946 T1 ATE258946 T1 AT E258946T1 AT 99943873 T AT99943873 T AT 99943873T AT 99943873 T AT99943873 T AT 99943873T AT E258946 T1 ATE258946 T1 AT E258946T1
- Authority
- AT
- Austria
- Prior art keywords
- chains
- conjugates
- proteins
- precise length
- producing polyamide
- Prior art date
Links
- 239000004952 Polyamide Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 229920002647 polyamide Polymers 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- 150000004985 diamines Chemical class 0.000 abstract 1
- 229920002521 macromolecule Polymers 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 239000000376 reactant Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
- C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
- C08G69/04—Preparatory processes
- C08G69/06—Solid state polycondensation
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
- C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
- C08G69/08—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
- C08G69/10—Alpha-amino-carboxylic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Polyamides (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9835198P | 1998-08-28 | 1998-08-28 | |
| US10526198P | 1998-10-22 | 1998-10-22 | |
| US12426699P | 1999-03-11 | 1999-03-11 | |
| PCT/US1999/019280 WO2000012587A2 (en) | 1998-08-28 | 1999-08-23 | Polyamide chains of precise length, methods to manufacture them and their conjugates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE258946T1 true ATE258946T1 (de) | 2004-02-15 |
Family
ID=27378582
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03023018T ATE364654T1 (de) | 1998-08-28 | 1999-08-23 | Polyamideketten von genauer länge und deren konjugate mit proteinen |
| AT99943873T ATE258946T1 (de) | 1998-08-28 | 1999-08-23 | Verfahren zur herstellung von polyamidketten von genauer länge und deren konjugate mit proteinen |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03023018T ATE364654T1 (de) | 1998-08-28 | 1999-08-23 | Polyamideketten von genauer länge und deren konjugate mit proteinen |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US6552167B1 (de) |
| EP (1) | EP1107998B1 (de) |
| JP (1) | JP2002528562A (de) |
| KR (1) | KR20010085742A (de) |
| CN (1) | CN1330675A (de) |
| AT (2) | ATE364654T1 (de) |
| AU (1) | AU764144B2 (de) |
| CA (1) | CA2351739A1 (de) |
| DE (3) | DE69936322T2 (de) |
| DK (1) | DK1400551T3 (de) |
| ES (1) | ES2170042T3 (de) |
| HK (1) | HK1043801A1 (de) |
| WO (1) | WO2000012587A2 (de) |
Families Citing this family (94)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HK1043801A1 (zh) * | 1998-08-28 | 2002-09-27 | 格莱风科学公司 | 精确长度的聚酰胺链、其制备方法和其与蛋白质的缀合物 |
| DE19924606A1 (de) * | 1999-05-28 | 2000-11-30 | Graffinity Pharm Design Gmbh | Ligand-Anker-Konjugate |
| US8183339B1 (en) | 1999-10-12 | 2012-05-22 | Xigen S.A. | Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| US20040082509A1 (en) | 1999-10-12 | 2004-04-29 | Christophe Bonny | Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| JP2004507557A (ja) * | 2000-09-01 | 2004-03-11 | グリフォン セラピューティクス，インコーポレーテッド | 求核物質に対して安定なチオエステル生成化合物、製造および使用の方法 |
| US7118737B2 (en) * | 2000-09-08 | 2006-10-10 | Amylin Pharmaceuticals, Inc. | Polymer-modified synthetic proteins |
| ATE500838T1 (de) * | 2000-09-08 | 2011-03-15 | Amylin Pharmaceuticals Inc | ßPSEUDOß-NATIVE CHEMISCHE LIGATION |
| JP4387669B2 (ja) | 2000-10-13 | 2009-12-16 | ザイジェン エス．アー． | 新規なトランスポーターペプチド配列による生物学的エフェクターの細胞内送達 |
| US7033597B2 (en) | 2000-10-13 | 2006-04-25 | Université de Lausanne | Intracellular delivery of biological effectors |
| US20040138412A1 (en) * | 2001-09-07 | 2004-07-15 | Paolo Botti | Extended native chemical ligation |
| US20040062748A1 (en) | 2002-09-30 | 2004-04-01 | Mountain View Pharmaceuticals, Inc. | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof |
| US8129330B2 (en) | 2002-09-30 | 2012-03-06 | Mountain View Pharmaceuticals, Inc. | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof |
| WO2004060925A2 (en) * | 2002-12-30 | 2004-07-22 | Gryphon Therapeutics, Inc. | Multiplex polymer ligation |
| WO2004061094A1 (en) | 2002-12-30 | 2004-07-22 | Gryphon Therapeutics, Inc. | Water-soluble thioester and selenoester compounds and methods for making and using the same |
| JP2007500218A (ja) | 2003-05-12 | 2007-01-11 | アフィーマックス・インコーポレイテッド | ポリ（エチレングリコール）修飾ペプチド系化合物の新規スペーサー部分 |
| DE602004020610D1 (de) * | 2003-05-12 | 2009-05-28 | Affymax Inc | Neue, an den erythropoietinrezeptor bindende peptide |
| ES2395413T3 (es) | 2003-05-12 | 2013-02-12 | Affymax, Inc. | Péptidos que se unen al receptor de eritropoyetina |
| EP1626983B8 (de) * | 2003-05-12 | 2010-12-22 | Affymax, Inc. | Neue poly(ethylenglycol) modifizierte erythropoietinagonisten und deren verwendungen |
| ES2642214T3 (es) | 2004-01-21 | 2017-11-15 | Novo Nordisk Health Care Ag | Conjugación de péptidos mediante transglutaminasa |
| AU2005319099B2 (en) * | 2004-02-02 | 2010-09-16 | Ambrx, Inc. | Modified human growth hormone |
| CN103755800B (zh) | 2004-02-02 | 2016-02-24 | Ambrx公司 | 经修饰的人类生长激素多肽与其用途 |
| US7588745B2 (en) * | 2004-04-13 | 2009-09-15 | Si Options, Llc | Silicon-containing products |
| CN102532321B (zh) * | 2004-06-18 | 2018-10-12 | Ambrx公司 | 新颖抗原结合多肽和其用途 |
| US7638299B2 (en) * | 2004-07-21 | 2009-12-29 | Ambrx, Inc. | Biosynthetic polypeptides utilizing non-naturally encoded amino acids |
| WO2006062685A2 (en) * | 2004-11-11 | 2006-06-15 | Affymax, Inc. | Novel peptides that bind to the erythropoietin receptor |
| WO2006060148A2 (en) * | 2004-11-11 | 2006-06-08 | Affymax, Inc. | Novel peptides that bind to the erythropoietin receptor |
| AU2005323106B2 (en) | 2004-12-22 | 2010-07-29 | Ambrx, Inc. | Methods for expression and purification of recombinant human growth hormone |
| NZ555425A (en) * | 2004-12-22 | 2010-04-30 | Ambrx Inc | Compositions of aminoacyl-tRNA synthetase and uses thereof |
| KR101224781B1 (ko) | 2004-12-22 | 2013-01-21 | 암브룩스, 인코포레이티드 | 비천연적으로 코딩된 아미노산을 포함하는 인간 성장호르몬의 조제물 |
| JP5410020B2 (ja) | 2005-02-02 | 2014-02-05 | ノヴォ ノルディスク アー／エス | インスリン誘導体 |
| WO2006133088A2 (en) | 2005-06-03 | 2006-12-14 | Ambrx, Inc. | Improved human interferon molecules and their uses |
| US7919461B2 (en) | 2005-06-03 | 2011-04-05 | Affymax, Inc. | Erythropoietin receptor peptide formulations and uses |
| US7550433B2 (en) | 2005-06-03 | 2009-06-23 | Affymax, Inc. | Erythropoietin receptor peptide formulations and uses |
| US8324159B2 (en) * | 2005-06-03 | 2012-12-04 | Affymax, Inc. | Erythropoietin receptor peptide formulations and uses |
| CA2618878C (en) | 2005-08-18 | 2016-06-28 | Ambrx, Inc. | Compositions of trna and uses thereof |
| US8080517B2 (en) | 2005-09-12 | 2011-12-20 | Xigen Sa | Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| WO2007031098A1 (en) | 2005-09-12 | 2007-03-22 | Xigen S.A. | Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| EP1951890A4 (de) | 2005-11-16 | 2009-06-24 | Ambrx Inc | Verfahren und zusammensetzungen mit nichtnatürlichen aminosäuren |
| ES2546282T3 (es) * | 2006-02-14 | 2015-09-22 | Novo Nordisk Health Care Ag | Acoplamiento de polipéptidos en el extremo C-terminal |
| AU2007267833B2 (en) | 2006-05-26 | 2012-07-26 | Amylin Pharmaceuticals, Llc | Composition and methods for treatment of congestive heart failure |
| WO2008019147A2 (en) * | 2006-08-04 | 2008-02-14 | Amylin Pharmaceuticals, Inc. | Use of exendins, exendin agonists and glp-1 receptor agonists for altering the concentration of fibrinogen |
| ES2531934T3 (es) | 2006-09-01 | 2015-03-20 | Novo Nordisk Health Care Ag | Glicoproteínas modificadas |
| WO2008030558A2 (en) * | 2006-09-08 | 2008-03-13 | Ambrx, Inc. | Modified human plasma polypeptide or fc scaffolds and their uses |
| ES2457527T3 (es) | 2006-09-08 | 2014-04-28 | Ambrx, Inc. | ARNt Supresor hibrido en células de vertebrados |
| PT2064333E (pt) | 2006-09-08 | 2014-06-09 | Ambrx Inc | Supressor híbrido arnt para células de vertebrados |
| WO2008067729A1 (fr) * | 2006-12-06 | 2008-06-12 | Nankai University | Polypeptides et leur procédé de synthèse |
| AU2007333049B2 (en) | 2006-12-15 | 2014-02-20 | Takeda Pharmaceutical Company Limited | Factor VIIa-(poly)sialic acid conjugate having prolonged in vivo half-life |
| KR101476472B1 (ko) | 2007-03-30 | 2015-01-05 | 암브룩스, 인코포레이티드 | 변형된 ｆｇｆ-21 폴리펩티드 및 그 용도 |
| KR20100019467A (ko) | 2007-05-02 | 2010-02-18 | 암브룩스, 인코포레이티드 | 변형된 인터페론 베타 폴리펩티드 및 그의 용도 |
| ES2632504T3 (es) | 2007-11-20 | 2017-09-13 | Ambrx, Inc. | Polipéptidos de insulina modificados y sus usos |
| NZ602170A (en) | 2008-02-08 | 2014-03-28 | Ambrx Inc | Modified leptin polypeptides and their uses |
| WO2009143865A1 (en) | 2008-05-30 | 2009-12-03 | Xigen S.A. | Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases |
| WO2009143864A1 (en) | 2008-05-30 | 2009-12-03 | Xigen S.A. | Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases |
| MX2011000859A (es) | 2008-07-23 | 2011-02-24 | Ambrx Inc | Polipeptidos g-csf bovinos modificados y sus usos. |
| NO2337846T3 (de) | 2008-09-26 | 2018-06-16 | ||
| PL2342223T3 (pl) | 2008-09-26 | 2017-09-29 | Ambrx, Inc. | Zmodyfikowane polipeptydy zwierzęcej erytropoetyny i ich zastosowania |
| WO2010072228A1 (en) | 2008-12-22 | 2010-07-01 | Xigen S.A. | Novel transporter constructs and transporter cargo conjugate molecules |
| WO2011012850A2 (en) | 2009-07-27 | 2011-02-03 | Lipoxen Technologies Limited | Glycopolysialylation of non-blood coagulation proteins |
| US8637640B2 (en) * | 2009-07-27 | 2014-01-28 | Baxter International Inc. | Blood coagulation protein conjugates |
| RU2744370C2 (ru) | 2009-07-27 | 2021-03-05 | Баксалта Инкорпорейтед | Конъюгаты белков свертывания крови |
| US8642737B2 (en) | 2010-07-26 | 2014-02-04 | Baxter International Inc. | Nucleophilic catalysts for oxime linkage |
| US8809501B2 (en) | 2009-07-27 | 2014-08-19 | Baxter International Inc. | Nucleophilic catalysts for oxime linkage |
| NZ600361A (en) | 2009-12-21 | 2014-06-27 | Ambrx Inc | Modified bovine somatotropin polypeptides and their uses |
| EP2516455A4 (de) | 2009-12-21 | 2013-05-22 | Ambrx Inc | Modifizierte schweine-somatotropin-polypeptide und deren verwendungen |
| WO2011160653A1 (en) | 2010-06-21 | 2011-12-29 | Xigen S.A. | Novel jnk inhibitor molecules |
| SMT201900495T1 (it) | 2010-08-17 | 2019-11-13 | Ambrx Inc | Polipeptidi di relaxina modificati e loro usi |
| US9567386B2 (en) | 2010-08-17 | 2017-02-14 | Ambrx, Inc. | Therapeutic uses of modified relaxin polypeptides |
| TWI480288B (zh) | 2010-09-23 | 2015-04-11 | Lilly Co Eli | 牛顆粒細胞群落刺激因子及其變體之調配物 |
| US9150618B2 (en) | 2010-10-14 | 2015-10-06 | Xigen Inflammation Ltd. | Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases |
| PL2654794T3 (pl) | 2010-12-22 | 2020-07-27 | Baxalta GmbH | Materiały i sposoby sprzęgania rozpuszczalnej w wodzie pochodnej kwasu tłuszczowego z białkiem |
| US8440309B2 (en) | 2011-01-31 | 2013-05-14 | Confluent Surgical, Inc. | Crosslinked polymers with the crosslinker as therapeutic for sustained release |
| WO2013091670A1 (en) | 2011-12-21 | 2013-06-27 | Xigen S.A. | Novel jnk inhibitor molecules for treatment of various diseases |
| JP6498600B2 (ja) | 2012-06-08 | 2019-04-10 | ストロ バイオファーマ インコーポレーテッド | 部位特異的な非天然アミノ酸残基を含む抗体、その調製方法、及びその使用方法 |
| EP2863955B1 (de) | 2012-06-26 | 2016-11-23 | Sutro Biopharma, Inc. | Modifizierte fc-proteine mit nichtnatürlichen ortsspezifische aminosäureresten, konjugate daraus, verfahren zu deren herstellung und verfahren zu deren verwendung |
| DK2890402T3 (da) | 2012-08-31 | 2019-07-15 | Sutro Biopharma Inc | Modificerede aminosyrer omfattende en azidogruppe |
| WO2014068463A2 (en) * | 2012-11-03 | 2014-05-08 | Mahesh Kandula | Compositions and methods for the treatment of inflammation and metabolic disorders |
| WO2014206427A1 (en) | 2013-06-26 | 2014-12-31 | Xigen Inflammation Ltd. | New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases |
| WO2015197097A1 (en) | 2014-06-26 | 2015-12-30 | Xigen Inflammation Ltd. | New use for jnk inhibitor molecules for treatment of various diseases |
| WO2014206563A2 (en) | 2013-06-26 | 2014-12-31 | Xigen Inflammation Ltd. | New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases |
| WO2015006555A2 (en) | 2013-07-10 | 2015-01-15 | Sutro Biopharma, Inc. | Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use |
| US9840493B2 (en) | 2013-10-11 | 2017-12-12 | Sutro Biopharma, Inc. | Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use |
| BR112017008157A2 (pt) | 2014-10-24 | 2017-12-19 | Bristol Myers Squibb Co | polipeptídeos de fgf-21 modificados e usos dos mesmos |
| WO2018136779A2 (en) | 2017-01-19 | 2018-07-26 | The University Of Chicago | OXALOBACTER FORMIGENES(Of)-DERIVED FACTORS FOR THE TREATMENT OF TREATMENT/PREVENTION OF EXCESS OXALATE LEVELS |
| US10266578B2 (en) | 2017-02-08 | 2019-04-23 | Bristol-Myers Squibb Company | Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof |
| EP3625247A4 (de) | 2017-05-16 | 2021-03-24 | The University of Chicago | Zusammensetzungen und verfahren zur behandlung und/oder vorbeugung von pathogenen pilzinfektionen und zur aufrechterhaltung von mikrobiomkommensalismus |
| US12016899B2 (en) | 2018-07-18 | 2024-06-25 | The University Of Chicago | Compositions comprising Sel1-derived peptides and methods of treatment/prevention of excess oxalate levels and associated conditions/diseases therewith |
| MX2021002575A (es) | 2018-09-11 | 2021-06-08 | Ambrx Inc | Conjugados de polipeptidos de interleucina-2 y sus usos. |
| AU2019361206A1 (en) | 2018-10-19 | 2021-06-03 | Ambrx, Inc. | Interleukin-10 polypeptide conjugates, dimers thereof, and their uses |
| CN119455003A (zh) | 2019-02-12 | 2025-02-18 | Ambrx公司 | 包含抗体-tlr激动剂缀合物的组合物、方法和用途 |
| CN110256668B (zh) * | 2019-06-04 | 2021-12-10 | 中国科学技术大学 | 高分子量呋喃基芳香聚酰胺及其制备方法和应用 |
| WO2021183832A1 (en) | 2020-03-11 | 2021-09-16 | Ambrx, Inc. | Interleukin-2 polypeptide conjugates and methods of use thereof |
| AU2021327396A1 (en) | 2020-08-20 | 2023-03-23 | Ambrx, Inc. | Antibody-TLR agonist conjugates, methods and uses thereof |
| MX2023011480A (es) | 2021-04-03 | 2023-12-06 | Ambrx Inc | Conjugados anticuerpo anti-her2-fármaco y usos de estos. |
| WO2026043823A2 (en) | 2024-08-19 | 2026-02-26 | Sutro Biopharma, Inc. | Antibodies comprising site-specific non-natural amino acid residues, methods of preparation and uses thereof |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE343210B (de) | 1967-12-20 | 1972-03-06 | Pharmacia Ab | |
| US4028315A (en) * | 1970-10-16 | 1977-06-07 | E. R. Squibb & Sons, Inc. | Solid phase synthesis of peptides |
| GB1479268A (en) | 1973-07-05 | 1977-07-13 | Beecham Group Ltd | Pharmaceutical compositions |
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| DE2360794C2 (de) | 1973-12-06 | 1984-12-06 | Hoechst Ag, 6230 Frankfurt | Verfahren zur Herstellung von Peptiden |
| US4028313A (en) * | 1975-06-25 | 1977-06-07 | Bayer Aktiengesellschaft | Process for the production of water-dispersible polyhydroxyl compounds |
| US4002531A (en) | 1976-01-22 | 1977-01-11 | Pierce Chemical Company | Modifying enzymes with polyethylene glycol and product produced thereby |
| GB1578348A (en) | 1976-08-17 | 1980-11-05 | Pharmacia Ab | Products and a method for the therapeutic suppression of reaginic antibodies responsible for common allergic |
| US4192798A (en) * | 1978-11-20 | 1980-03-11 | Bioresearch, Inc. | Rapid, large scale, automatable high pressure peptide synthesis |
| JPS5792435A (en) | 1980-11-28 | 1982-06-09 | Matsushita Electric Ind Co Ltd | Formation of magnetic tape |
| US4415665A (en) | 1980-12-12 | 1983-11-15 | Pharmacia Fine Chemicals Ab | Method of covalently binding biologically active organic substances to polymeric substances |
| US4414147A (en) | 1981-04-17 | 1983-11-08 | Massachusetts Institute Of Technology | Methods of decreasing the hydrophobicity of fibroblast and other interferons |
| JPS57206622A (en) | 1981-06-10 | 1982-12-18 | Ajinomoto Co Inc | Blood substitute |
| US4609546A (en) | 1982-06-24 | 1986-09-02 | Japan Chemical Research Co., Ltd. | Long-acting composition |
| IL74177A (en) | 1984-02-03 | 1989-09-10 | Abbott Lab | Stabilized enzyme conjugate composition containing a calcium salt and a polyethylene glycol |
| US4732863A (en) | 1984-12-31 | 1988-03-22 | University Of New Mexico | PEG-modified antibody with reduced affinity for cell surface Fc receptors |
| US4824659A (en) * | 1985-06-07 | 1989-04-25 | Immunomedics, Inc. | Antibody conjugates |
| IT1190389B (it) * | 1985-09-19 | 1988-02-16 | Eniricerche Spa | Esapeptidi ad attivita' ipotensiva |
| US4802512A (en) | 1986-02-25 | 1989-02-07 | Kabushiki, Kaisha, Kodera, Denshi, Seisakusho | Automatic wire decorticating and cutting method and apparatus |
| US4745180A (en) | 1986-06-27 | 1988-05-17 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using heparin fragments |
| US5122614A (en) | 1989-04-19 | 1992-06-16 | Enzon, Inc. | Active carbonates of polyalkylene oxides for modification of polypeptides |
| US5097070A (en) * | 1989-11-03 | 1992-03-17 | Texaco Chemical Company | High molecular weight trifunctional polyoxyethylene amines |
| DE69322266T2 (de) | 1992-04-03 | 1999-06-02 | Perkin-Elmer Corp., Foster City, Calif. | Proben zusammensetzung und verfahren |
| IL107715A0 (en) * | 1992-11-25 | 1994-02-27 | Baxter Int | Water soluble non-immunogenic polyamide cross-linking agents |
| FR2698628B1 (fr) * | 1992-12-02 | 1995-02-17 | Fournier Ind & Sante | Analogues de 15-déoxyspergualine, leur procédé de préparation et leur utilisation en thérapeutique. |
| NZ250375A (en) | 1992-12-09 | 1995-07-26 | Ortho Pharma Corp | Peg hydrazone and peg oxime linkage forming reagents and protein derivatives |
| JP3351476B2 (ja) | 1993-01-22 | 2002-11-25 | 三菱化学株式会社 | リン脂質誘導体及びそれを含有するリポソーム |
| US5446090A (en) | 1993-11-12 | 1995-08-29 | Shearwater Polymers, Inc. | Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules |
| WO1995017886A1 (en) * | 1993-12-27 | 1995-07-06 | Baxter International Inc. | Water soluble non-immunogenic polyamide cross-linking agents |
| US5672662A (en) | 1995-07-07 | 1997-09-30 | Shearwater Polymers, Inc. | Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications |
| AU730969B2 (en) | 1995-10-19 | 2001-03-22 | University Of Washington | Discrete-length polyethylene glycols |
| HK1043801A1 (zh) * | 1998-08-28 | 2002-09-27 | 格莱风科学公司 | 精确长度的聚酰胺链、其制备方法和其与蛋白质的缀合物 |
-
1999
- 1999-08-23 HK HK02104731.4A patent/HK1043801A1/zh unknown
- 1999-08-23 CN CN99812465A patent/CN1330675A/zh active Pending
- 1999-08-23 EP EP99943873A patent/EP1107998B1/de not_active Expired - Lifetime
- 1999-08-23 AU AU56883/99A patent/AU764144B2/en not_active Ceased
- 1999-08-23 DE DE69936322T patent/DE69936322T2/de not_active Expired - Fee Related
- 1999-08-23 CA CA002351739A patent/CA2351739A1/en not_active Abandoned
- 1999-08-23 DE DE69914611T patent/DE69914611T2/de not_active Expired - Fee Related
- 1999-08-23 US US09/379,297 patent/US6552167B1/en not_active Expired - Fee Related
- 1999-08-23 JP JP2000567596A patent/JP2002528562A/ja active Pending
- 1999-08-23 WO PCT/US1999/019280 patent/WO2000012587A2/en not_active Ceased
- 1999-08-23 ES ES99943873T patent/ES2170042T3/es not_active Expired - Lifetime
- 1999-08-23 DK DK03023018T patent/DK1400551T3/da active
- 1999-08-23 AT AT03023018T patent/ATE364654T1/de not_active IP Right Cessation
- 1999-08-23 AT AT99943873T patent/ATE258946T1/de not_active IP Right Cessation
- 1999-08-23 KR KR1020017002641A patent/KR20010085742A/ko not_active Withdrawn
- 1999-08-24 DE DE1107998T patent/DE1107998T1/de active Pending
-
2003
- 2003-03-06 US US10/379,585 patent/US20030228274A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002528562A (ja) | 2002-09-03 |
| WO2000012587A8 (en) | 2001-09-20 |
| HK1043801A1 (zh) | 2002-09-27 |
| US20030228274A1 (en) | 2003-12-11 |
| ES2170042T3 (es) | 2004-10-01 |
| CA2351739A1 (en) | 2000-03-09 |
| DE69914611D1 (de) | 2004-03-11 |
| ES2170042T1 (es) | 2002-08-01 |
| WO2000012587A3 (en) | 2000-06-02 |
| DE69936322D1 (de) | 2007-07-26 |
| AU5688399A (en) | 2000-03-21 |
| KR20010085742A (ko) | 2001-09-07 |
| DK1400551T3 (da) | 2007-10-15 |
| DE69936322T2 (de) | 2008-02-21 |
| AU764144B2 (en) | 2003-08-14 |
| DE69914611T2 (de) | 2004-12-23 |
| EP1107998B1 (de) | 2004-02-04 |
| WO2000012587A2 (en) | 2000-03-09 |
| CN1330675A (zh) | 2002-01-09 |
| ATE364654T1 (de) | 2007-07-15 |
| EP1107998A2 (de) | 2001-06-20 |
| US6552167B1 (en) | 2003-04-22 |
| DE1107998T1 (de) | 2002-10-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69914611D1 (de) | Verfahren zur herstellung von polyamidketten von genauer länge und deren konjugate mit proteinen | |
| DE69831402D1 (de) | Nicht antigen wirkende verzweigte polymerkonjugate | |
| CA2174325A1 (en) | Non-antigenic branched polymer conjugates | |
| DE69633669D1 (de) | Verfahren zur zelltransfektion mit liposomal-verkapselten nukleinsäuren | |
| NO975729L (no) | Forbindelser og peptider som binder til etytropoietinreseptoren | |
| CY1109480T1 (el) | ΠΡΩΤΕΪΝΕΣ ΣΥΝΔΕΣΗΣ Gag | |
| DE69028412D1 (de) | Verfahren zum transport von molekülen in eukaryotenzellen | |
| DE68903482D1 (de) | Zement, verfahren zur herstellung dieses zements und verfahren zur herstellung von produkten mit diesem zement. | |
| HK1049283A1 (zh) | 兩性聚合物及含其的多肽共軛物 | |
| CY1112101T1 (el) | Νευροτροφικοι παραγοντες | |
| DE69033705D1 (de) | Hybride immunglobuline | |
| DK113790D0 (da) | Vandig gel paa basis af hyaluronsyre og desoxyribonucleinsyre anvendelig i kosmetik og fremgangsmaade til fremstilling deraf | |
| DE3675887D1 (de) | Elektronisch leitfaehige stickstoffpolymere, verfahren zur herstellung derselben, elektrochronische anzeigezelle, und diese polymere verwendender elektrochemischer generator. | |
| ES2120964T3 (es) | Peptidos osteogenicos. | |
| SE8804164D0 (sv) | Farmaceutisk beredning | |
| MX9306918A (es) | Composicion y metodo para la absorcion mejorada de fertilizante enplantas. | |
| DE60018564D1 (de) | Funktionsfähige poly-alpha-aminosäurederivate zur modifizierung von biologisch wirksamen stoffen und deren herstellung | |
| ATE527358T1 (de) | Ribosomen inaktivierendes protein vom typ-1 | |
| DE59703693D1 (de) | Pflanzenbehandlungsmittel | |
| DE60315274D1 (de) | Herstellungsverfahren von copolyestercarbonaten | |
| ES549185A0 (es) | Procedimiento para sintetizar peptidos a partir de aminoaci-dos | |
| ATE481641T1 (de) | Verfahren zur fixierung eines proteins auf einem pyrrolpolymerisat, und dessen verwendung zur herstellung eines sensors | |
| ATA7997A (de) | Verfahren zur herstellung von chitosan-ethylendiamintetraacetat konjugaten | |
| DE59701734D1 (de) | Unlösliche, nur wenig quellbare polymerisate mit modifizierten aminogruppen, verfahren zu ihrer herstellung und ihre verwendung | |
| ATE248807T1 (de) | Verfahren zur herstellung von n-hydrocarbyl- substituierten amiden |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |